Study Finds New Chemo Combo May be Better for Some Non-Hodgkin’s...

Researchers say a combination of bendamustine and rituximab may be just as effective and less toxic than standard chemotherapy for indolent lymphomas.(PRWeb March 12, 2014)Read the full story at http://www.prweb.com/releases/2014/03/prweb11642851.htm
Source: PRWeb: Medical Pharmaceuticals - Category: Pharmaceuticals Source Type: news